Search Within

Ghassan Abou-Alfa

Formats
  1. Meeting Abstract (268)
  2. Journal Article (247)
  3. Review (27)
  4. Book Section (16)
  5. Editorial (8)
  6. Book Whole (4)
  7. Correspondence (4)
  8. Guidelines (4)
  9. Miscellaneous (3)
  10. Research Letter (1)
Groups
  1. Department of Medicine (582)
  2. Gastrointestinal Oncology Service (582)
  3. Solid Tumor Oncology Division (582)
  4. Center for Pancreatic Cancer Research (218)
  5. Epidemiology and Biostatistics (124)
  6. Surgery (103)

More Groups

People
  1. Eileen O'Reilly (159)
  2. James Harding (134)
  3. Marinela Capanu (67)
  4. William Jarnagin (66)
  5. Leonard Saltz (55)
  6. Imane El Dika (54)

More People

Years
  1. 2025 (27)
  2. 2024 (52)
  3. 2023 (48)
  4. 2022 (53)
  5. 2021 (46)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (167)
  2. Annals of Oncology (57)
  3. Gastrointestinal Cancer Research (21)
  4. Oncology Research and Treatment (18)
  5. Annals of Surgical Oncology (15)
  6. Cancer (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (183)
  2. Oxford University Press (69)
  3. Springer (36)
  4. Wiley Blackwell (30)
  5. Elsevier Inc. (25)
  6. Elsevier Science, Inc. (24)

More Publishers

Results (582)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Platinum-based combination therapy (PCT) and outcomes for patients (pts) with mixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma (mHCC/ICC)
    Meeting Abstract

    Connell, L. C.; Harding, J. J.; Lowery, M. A.; Kemeny, N. E.; Cercek, A.; Abdelgawad, M. I.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Abou-Alfa, G. K.; Mayer, R. J.; Cosgrove, D.; Capanu, M.; Choti, M. A.; Atreya, C. E.; Ang, C.; Kelley, R. K.; Do, R. K. G.; Gordan, J. D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Locoregional therapy for hepatocellular carcinoma with and without extrahepatic spread
    Journal Article

    Leal, J. N.; Gonen, M.; Covey, A. M.; Erinjeri, J. P.; Getrajdman, G.; Sofocleous, C. T.; D'Angelica, M.; DeMatteo, R. P.; Abou-Alfa, G. K.; Jarnagin, W. R.; more...
    Journal of Vascular and Interventional Radiology (2015)

    Fulltext@MSK | Save
  • Effect of coadministration of propranolol and etodolac (VT-122) plus sorafenib for patients with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    de la Torre, A. N.; Castaneda, I.; Hezel, A. F.; Bascomb, N. F.; Bhattacharyya, G. S.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinoma to identify potential therapeutic options
    Meeting Abstract

    Abou-Alfa, G. K.; Miura, J. T.; Gamblin, T. C.; Xiu, J.; Millis, S. Z.; Gatalica, Z.; Reddy, S. K.; Ang, C.; Yee, N. S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The DASH Study: A phase 1b study of dalantercept plus sorafenib in advanced hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Miksad, R. A.; Gutierrez, M.; Tejani, M. A.; Sharma, M.; Sun, W. J.; Henderson, C. A.; Baron, A. D.; Olowokure, O. O.; Pearsall, R. S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase 3 randomized, double-blind, controlled study of cabozantinib (XL184) versus placebo in subjects with hepatocellular carcinoma who have received prior sorafenib (CELESTIAL; NCT01908426)
    Meeting Abstract

    Abou-Alfa, G. K.; Cheng, A. L.; Meyer, T.; El-Khoueiry, A. B.; Ikeda, M.; Chun, H. G.; Furuse, J.; Knox, J. J.; Okusaka, T.; Ping, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Consensus conference on intrahepatic cholangiocarcinoma
    Journal Article

    Abou-Alfa, G. K.; Geschwind, J. F.; Choti, M.; D'Angelica, M. I.
    HPB (2015)

    Fulltext@MSK | Save
  • Hospitalists on an inpatient tertiary care oncology teaching service
    Journal Article

    Koo, D. J.; Goring, T. N.; Saltz, L. B.; Kerpelev, M.; Kumar, C. B.; Salvit, C.; Chung, H. H.; Abou-Alfa, G. K.; Martin, S. C.; Egan, B. C.
    Journal of Oncology Practice (2015)

    Fulltext@MSK | Save